SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-15-008216
Filing Date
2015-09-30
Accepted
2015-09-30 08:30:13
Documents
3
Period of Report
2015-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mstx-8k_20150928.htm 8-K 39334
2 EX-99.1 mstx-ex991_6.htm EX-99.1 19665
3 GRAPHIC g20150929181039391188.jpg GRAPHIC 4304
  Complete submission text file 0001564590-15-008216.txt   66675
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 151132784
SIC: 2834 Pharmaceutical Preparations